Dexmedetomidine Versus Propofol in Vitreoretinal Surgery

Completed · Phase 4

Conditions studied: Retinal Detachment

In brief

The investigators would like to determine if using Dexmedetomidine alone or in a reduced dose can prevent or reduce the incidence of adverse effects, while providing adequate sedation, and respiratory stability as compared to propofol.

Key facts

Study ID

NCT01001429

Run by

Rutgers, The State University of New Jersey

People needed

78

Starts

2009-10-01

Expected to finish

2013-11-01

Last updated by the study team

2017-08-21

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• American Society of Anesthesiologists rating of I-III
• good renal and liver function

You may not qualify if…

• renal and hepatic insufficiency
• uncontrolled diabetes
• uncontrolled hypertension
• severe cardiac disease Class III or IV
• heart blocks
• chronic use of sedatives, narcotics, alcohol or illicit drugs
• allergy to either propofol or dexmedetomidine
• pregnancy or inability to tolerate technique of the study drugs

Where it is running

• UMDNJ-University Hospital — Newark, New Jersey, United States
• University Hospital — Newark, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.